# NALOXONE HYDROCHLORIDE
> **ANDA216719** · Abbreviated New Drug Application (Generic) · Sponsor: PADAGIS ISRAEL · Approved 2025-04-24
## Drug
- **FDA Application Number:** ANDA216719
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NALOXONE HYDROCHLORIDE
- **Generic name:** Naloxone Hydrochloride
- **Active ingredients:** NALOXONE HYDROCHLORIDE
- **Dosage form:** SPRAY
- **Route:** NASAL
- **Marketing status:** Discontinued
- **Sponsor:** PADAGIS ISRAEL
- **First approval:** 2025-04-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216719)
---
*MORVS · CC0 1.0*